Also trades as: IPN.PA (PAR) · $vol 18M · IPSEF (OTC) · $vol 0M

$41.90

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 34 · $55.4B mcap · 101M float · 0.0007% daily turnover · Short 61% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$3.5B -1.2% ▼

5Y CAGR: +5.6%

Gross Profit

$2.5B -15.7% ▼

5Y CAGR: +2.6%

Operating Income

$717M +44.3% ▲

5Y CAGR: +6.4%

Net Income

$427M +23.4% ▲

5Y CAGR: -4.9%

EPS (Diluted)

$1.28 +23.1% ▲

5Y CAGR: -4.8%

EBITDA

$1.1B -8.8% ▼

5Y CAGR: +5.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.7B	$3.2B	$3.3B	$3.6B	$3.5B
YoY Growth	+2.3%	+14.8%	+4.7%	+8.1%	-1.2%
Cost of Revenue	$538M	$528M	$571M	$619M	$1.0B
Gross Profit	$2.3B	$2.6B	$2.7B	$3.0B	$2.5B
Gross Margin	84.0%	83.3%	82.7%	82.7%	70.6%
R&D Expenses	$428M	$445M	$619M	$687M	$0
SG&A Expenses	$1.0B	$1.0B	$1.1B	$1.2B	$0
Operating Expenses	$1.5B	$1.9B	$1.9B	$2.5B	$1.8B
Operating Income	$825M	$730M	$816M	$497M	$717M
Operating Margin	30.0%	23.1%	24.7%	13.9%	20.3%
Interest Expense	$24M	$18M	$38M	$24M	$35M
Income Before Tax	$789M	$704M	$756M	$432M	$555M
Tax Expense	$158M	$112M	$136M	$75M	$128M
Net Income	$647M	$649M	$644M	$346M	$427M
Net Margin	23.5%	20.5%	19.5%	9.7%	12.1%
EPS (Diluted)	$1.89	$1.79	$1.85	$1.04	$1.28
EBITDA	$1.1B	$1.1B	$887M	$1.2B	$1.1B
Shares Outstanding	333M	332M	334M	334M	334M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$1.6B	$1.5B	$1.6B	$1.8B	$1.8B	$1.9B	$1.8B	$2.3B
Cost of Revenue	$286M	$270M	$301M	$317M	$302M	$325M	$554M	$566M
Gross Profit	$1.3B	$1.3B	$1.3B	$1.4B	$1.5B	$1.6B	$1.3B	$1.7B
Gross Margin	82.1%	82.4%	81.1%	81.9%	83.4%	83.2%	69.9%	71.9%
R&D Expenses	$238M	$290M	$329M	$323M	$363M	$365M	$359M	$410M
SG&A Expenses	$552M	$553M	$582M	$575M	$599M	$607M	$556M	$608M
Operating Expenses	$723M	$756M	$819M	$1.1B	$1.3B	$1.2B	$804M	$1.3B
Operating Income	$583M	$510M	$471M	$318M	$179M	$452M	$265M	$565M
Operating Margin	36.6%	33.2%	29.6%	18.1%	9.8%	23.3%	14.4%	24.6%
Interest Expense	$12M	$15M	$11M	$11M	$13M	$4M	$20M	$21M
Income Before Tax	$214M	$261M	$529M	$290M	$143M	$425M	$130M	$548M
Tax Expense	$4M	$56M	$80M	$47M	$28M	$90M	$39M	$145M
Net Income	$254M	$195M	$449M	$232M	$114M	$334M	$109M	$403M
Net Margin	16.0%	12.7%	28.2%	13.2%	6.2%	17.2%	5.9%	17.5%
EPS (Diluted)	$0.64	$0.59	$1.35	$0.73	$0.34	$1.00	$0.28	$1.22
EBITDA	$669M	$480M	$407M	$482M	$680M	$678M	$381M	$816M
Shares Outstanding	332M	332M	334M	334M	333M	334M	329M	332M

IPSEY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet